Related Articles
Acquired resistance L747S mutation in an epidermal growth factor receptor‑tyrosine kinase inhibitor‑naïve patient: A report of three cases
Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population
ALK inhibitors and advanced non-small cell lung cancer (Review)
Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review)
Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑naïve non‑small cell lung carcinoma